CAS: 526-84-1; 2,3-Dihydroxymaleic Acid

该化合物是一种有机化合物,是雄性酸的衍生物,其特点是存在两个氢氧基(OH)组,该化合物一般是白色晶状固体,由于其极性氢氧基组,在水中可溶解.二氢氧汞酸因其能够参与各种化学反应,包括酯化和聚合,使其对有机合成和材料科学感兴趣而闻名.其结构允许在生产生物降解聚合物和作为合成更复杂的有机分子的建筑块中潜在应用.此外,多种功能组的存在会影响其再活动及与其他化学物种的相互作用.与许多有机酸一样,它可能具有酸性,有助于其在不同的化学环境中的行为.应当参考安全数据,以便处理和储存任何化学物质.

结构式图片

相似化合物

13096-38-3 133-47-1 2215-12-5

MSDS等安全信息

上下游产品

CAS号87-69-4 酒石酸 | CAS号7732-18-5 水 | CAS号10035-10-6 氢溴酸 | CAS号64-19-7 冰醋酸 | CAS号7580-59-8 2,3-二氧代琥珀酸 | CAS号473-90-5 中草酸 | CAS号76-30-2 二羟基酒石酸 | CAS号141-46-8 羟乙醛 | CAS号75640-08-3 Propanoicacid, ... | CAS号7580-59-8 2,3-二氧代琥珀酸 | CAS号815-53-2 2,3-dioxopropan...

合成工艺路线路线简述

    📜Dioxo-Succinic Acid ; Potassium Compound,Alkaline Earth Salt Of/the/ Methylsulfuric Acid 反应生成 二羟基顺丁烯二酸
    参考文献:Fenton,Journal Of The Chemical Society,1898,Vol. 73,P. 480
    标题:Fenton,Journal Of The Chemical Society,1898,Vol. 73,P. 480

    海关参考信息

    专利信息


    专利号:WO-0200681-A1
    优先权日:2000-06-27
    标题 :20-fluoro-17(20)-vinyl steroids as inhibitors of c17-20-lyase and 5-alpha reductase
    发明人:PEET NORTON P; WEINTRAUB PHILIP M; BURKHART JOSEPH P; GATES CYNTHIA A
    权利人:AVENTIS PHARMA INC; PEET NORTON P; WEINTRAUB PHILIP M; BURKHART JOSEPH P; GATES CYNTHIA A
    摘要:The invention related to 20κ-fluoropregna-4,17(20)-dien-3-on-21-oic acid ethyl ester, 20κ-fluoro-3β-hydroxypregna-4,17(20)-dien-21-oic acid ethyl ester, 20κ-fluoro-21-hydroxypregna-4,17(20)-dien-3-one, 20κ-fluoropregna-4,17(20)-dien-3β,21-diol and related compounds and to compositions incorporating these compounds, as well as the inhibition of C17,20 lyase, 5α-reductase and C17-hydroxylase, and to the use of these compounds in the treatment of androgen and estrogen mediated or dependent disorders, including benign prostatic hyperplasia, prostate cancer, breast cancer and DHT-mediated disorders such as acne and hirsutism. Treatment of disorders related to the over synthesis of cortisol, for example, Cushing's Syndrome are also included. The treatment of androgen-dependent disorders also includes a combination therapy with known androgen-receptor antagonists, such as flutamide. The compounds of the invention have general formulae (I).

    专利号:US-4107210-A
    优先权日:1976-09-07
    标 题 :Synthesis of alpha-diketones
    发明人:FREITER EDWARD R
    权利人:DOW CHEMICAL CO
    摘要:Alpha-diketones, such as 1-phenyl-1,2-propanedione and 1-propyl-1,2-butanedione, are prepared by reacting an acylmethyl ester of a carboxylic acid (e.g., benzoylmethyl acetate or butanoylmethyl propionate) with an aldehyde, such as formaldehyde or acetaldehyde, in the presence of an acid catalyst and water. Such alpha-diketones are also obtained by first refluxing a mixture of an alpha-haloketone and a carboxyl anion source and then reacting the mixture with an aldehyde in the presence of an acid catalyst and water.

    专利号:US-6413951-B2
    优先权日:2000-06-27
    标题:20-fluoro-17(20)-vinyl steroids
    发明人:PEET NORTON P; WEINTRAUB PHILIP M; BURKHART JOSEPH P; GATES CYNTHIA A
    权利人:AVENTIS PHARMA INC
    摘要:The invention relates to 20ξ-fluoropregna-4,17(20)-dien-3-on-21-oic acid ethyl ester, 20ξ-fluoro-3beta-hydroxypregna-5,17(20)-dien-21-oic acid ethyl ester, 20ξ-fluoro-21-hydroxypregna-4,17 (20)-dien-3-one, 20ξ-fluoropregna-5,17(20)-dien-3beta,21-diol and related compounds and to compositions incorporating these compounds, as well as the inhibition of C17,20 lyase, 5alpha-reductase and C17-hydroxylase, and to the use of these compounds in the treatment of androgen and estrogen mediated or dependent disorders, including benign prostatic hyperplasia, prostate cancer, breast cancer and DHT-mediated disorders such as acne and hirsutism. Treatment of disorders related to the over synthesis of cortisol, for example, Cushing's Syndrome are also included. The treatment of androgen-dependent disorders also includes a combination therapy with known androgen-receptor antagonists, such as flutamide. The compounds of the invention have the following general formulae:

    专利号:US-3948876-A
    优先权日:1973-12-14
    标 题 :Process for the purification of synthetic calcitonins
    发明人:RITTEL WERNER; BRUGGER MAX; RINIKER BERNHARD
    权利人:CIBA GEIGY CORP
    摘要:Peptides of the calcitonin type when obtained by synthesis can be purified in a simple manner by forming inner salts, which precipitate from aqueous solutions of salts of the peptides with acids or bases when these solutions are adjusted to the isoelectric range. Impurities remain in solution, while the inner salts separate practically quantitatively. The precipitation is completed after several hours. The peptides can then be recuperated by treatment with an acid, especially a therapeutically suitable acid. The process affords products which are superior to those obtained by purification methods hitherto known and gives higher yields. Other long-chain peptides such as ACTH, insulin or glucagon cannot be purified in this manner.

    专利号:EP-0723958-A1
    优先权日:1993-06-24
    标 题:Synthesis of substantially pure terfenadine derivatives

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Merck Index - O'Neil MJ, Heckelman PE, Dobbelaar PH, Roman KJ (eds). The Merck Index, An Encyclopedia of Chemicals, Drugs, and Biologicals, 15th Ed. Cambridge, UK: The Royal Society of Chemistry, 2013.
    摘要:Boyd, G. V., Science of Synthesis, (2002) 11, 394.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知